These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1712591)

  • 1. Murine strain differences in pulmonary bleomycin metabolism.
    Filderman AE; Lazo JS
    Biochem Pharmacol; 1991 Jun; 42(1):195-8. PubMed ID: 1712591
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity.
    Lazo JS; Humphreys CJ
    Proc Natl Acad Sci U S A; 1983 May; 80(10):3064-8. PubMed ID: 6190169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bleomycin-induced pulmonary toxicity and related factors to that toxicity in experimental animals].
    Okayama H
    Tsurumi Shigaku; 1986 May; 12(2):245-57. PubMed ID: 2429414
    [No Abstract]   [Full Text] [Related]  

  • 4. Alterations in pulmonary protective enzymes following systemic bleomycin treatment in mice.
    Filderman AE; Genovese LA; Lazo JS
    Biochem Pharmacol; 1988 Mar; 37(6):1111-6. PubMed ID: 2451525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic inactivation of bleomycin analogs by bleomycin hydrolase.
    Sebti SM; Lazo JS
    Pharmacol Ther; 1988; 38(3):321-9. PubMed ID: 2461572
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute pulmonary toxicity of bleomycin: DNA scission and matrix protein mRNA levels in bleomycin-sensitive and -resistant strains of mice.
    Harrison JH; Hoyt DG; Lazo JS
    Mol Pharmacol; 1989 Aug; 36(2):231-8. PubMed ID: 2475758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma and pulmonary pharmacokinetics of bleomycin in murine strains that are sensitive and resistant to bleomycin-induced pulmonary fibrosis.
    Harrison JH; Lazo JS
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1052-8. PubMed ID: 2462625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental bleomycin lung in mice. A contribution to the pathogenesis of pulmonary fibrosis.
    Fasske E; Morgenroth K
    Lung; 1983; 161(3):133-46. PubMed ID: 6192292
    [No Abstract]   [Full Text] [Related]  

  • 9. Murine susceptibility to radiation-induced pulmonary fibrosis is influenced by a genetic factor implicated in susceptibility to bleomycin-induced pulmonary fibrosis.
    Haston CK; Travis EL
    Cancer Res; 1997 Dec; 57(23):5286-91. PubMed ID: 9393751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of bleomycin hydrolase with a monoclonal antibody and its characterization.
    Nishimura C; Tanaka N; Suzuki H; Tanaka N
    Biochemistry; 1987 Mar; 26(6):1574-8. PubMed ID: 3109467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleomycin.
    Lazo JS
    Cancer Chemother Biol Response Modif; 1999; 18():39-45. PubMed ID: 10800476
    [No Abstract]   [Full Text] [Related]  

  • 12. Bleomycin hydrolase and a genetic locus within the MHC affect risk for pulmonary fibrosis in mice.
    Haston CK; Wang M; Dejournett RE; Zhou X; Ni D; Gu X; King TM; Weil MM; Newman RA; Amos CI; Travis EL
    Hum Mol Genet; 2002 Aug; 11(16):1855-63. PubMed ID: 12140188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spleen tyrosine kinase (Syk) inhibitor fostamatinib limits tissue damage and fibrosis in a bleomycin-induced scleroderma mouse model.
    Pamuk ON; Can G; Ayvaz S; Karaca T; Pamuk GE; Demirtas S; Tsokos GC
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S15-22. PubMed ID: 26148346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleomycin-resistant cells contain increased bleomycin-hydrolase activities.
    Akiyama S; Ikezaki K; Kuramochi H; Takahashi K; Kuwano M
    Biochem Biophys Res Commun; 1981 Jul; 101(1):55-60. PubMed ID: 6169344
    [No Abstract]   [Full Text] [Related]  

  • 15. Bleomycin hydrolase activity in pulmonary cells.
    Lazo JS; Merrill WW; Pham ET; Lynch TJ; McCallister JD; Ingbar DH
    J Pharmacol Exp Ther; 1984 Dec; 231(3):583-8. PubMed ID: 6209387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kinetics and mechanism in bleomycin-induced murine pulmonary fibrosis model].
    Hu P; Gao ZC
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Aug; 18(8):474-8. PubMed ID: 16887059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleomycin and pulmonary toxicity.
    Van Barneveld PW; Mulder NH; Van der Mark TW; Sleijfer DT
    Neth J Med; 1985; 28(11):516-23. PubMed ID: 2417127
    [No Abstract]   [Full Text] [Related]  

  • 18. Association analysis reveals genetic variation altering bleomycin-induced pulmonary fibrosis in mice.
    Paun A; Lemay AM; Tomko TG; Haston CK
    Am J Respir Cell Mol Biol; 2013 Mar; 48(3):330-6. PubMed ID: 23239499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gefitinib attenuates murine pulmonary fibrosis induced by bleomycin.
    Wang P; Tian Q; Liang ZX; Yang Z; Xu SF; Sun JP; Chen LA
    Chin Med J (Engl); 2010 Aug; 123(16):2259-64. PubMed ID: 20819676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
    Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
    Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.